Physical Activity Levels and Statin Therapy

NCT05625945 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 196

Last updated 2023-11-18

No results posted yet for this study

Summary

Rationale: Combining statin treatment and physical activity is very effective for the prevention of cardiovascular diseases. Statins are well-tolerated by most patients, but may cause statin-associated muscle symptoms (SAMS).

Objective: To identify predictors for SAMS in statin users and to objectively assess physical activity levels and sedentary time between symptomatic and asymptomatic statin users.

Conditions

Interventions

BEHAVIORAL

Physical activity monitoring

Physical activity patterns will be measured using the activPAL3 micro monitor

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-11-16
Completion
2023-11-16

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05625945 on ClinicalTrials.gov